PT1007685E - Proteinas expostas na superficie da chlamydia pneumoniae - Google Patents

Proteinas expostas na superficie da chlamydia pneumoniae

Info

Publication number
PT1007685E
PT1007685E PT98928179T PT98928179T PT1007685E PT 1007685 E PT1007685 E PT 1007685E PT 98928179 T PT98928179 T PT 98928179T PT 98928179 T PT98928179 T PT 98928179T PT 1007685 E PT1007685 E PT 1007685E
Authority
PT
Portugal
Prior art keywords
kda
proteins
chlamydia pneumoniae
pneumoniae
relates
Prior art date
Application number
PT98928179T
Other languages
English (en)
Portuguese (pt)
Inventor
Svend Birkelund
Gunna Christiansen
Katrine Knudsen
Anna-Sofie Hebsgaard Pedersen
Per Mygind
Original Assignee
Loke Diagnostics Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Loke Diagnostics Aps filed Critical Loke Diagnostics Aps
Publication of PT1007685E publication Critical patent/PT1007685E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/125—Gram-negative bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PT98928179T 1997-06-23 1998-06-19 Proteinas expostas na superficie da chlamydia pneumoniae PT1007685E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK74497 1997-06-23

Publications (1)

Publication Number Publication Date
PT1007685E true PT1007685E (pt) 2006-08-31

Family

ID=8097044

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98928179T PT1007685E (pt) 1997-06-23 1998-06-19 Proteinas expostas na superficie da chlamydia pneumoniae

Country Status (13)

Country Link
US (2) US7264941B1 (cg-RX-API-DMAC10.html)
EP (1) EP1007685B1 (cg-RX-API-DMAC10.html)
JP (1) JP4160640B2 (cg-RX-API-DMAC10.html)
CN (1) CN1249233C (cg-RX-API-DMAC10.html)
AT (1) ATE323164T1 (cg-RX-API-DMAC10.html)
AU (1) AU749382B2 (cg-RX-API-DMAC10.html)
BR (1) BR9810288A (cg-RX-API-DMAC10.html)
CA (1) CA2294651A1 (cg-RX-API-DMAC10.html)
DE (1) DE69834194T2 (cg-RX-API-DMAC10.html)
DK (1) DK1007685T3 (cg-RX-API-DMAC10.html)
ES (1) ES2264810T3 (cg-RX-API-DMAC10.html)
PT (1) PT1007685E (cg-RX-API-DMAC10.html)
WO (1) WO1998058953A2 (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
US6649370B1 (en) * 1998-10-28 2003-11-18 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
EP1129202A2 (en) * 1998-10-28 2001-09-05 Aventis Pasteur Limited Chlamydia antigenes and corresponding dna fragments and uses thereof
US6872814B2 (en) * 1998-10-29 2005-03-29 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
NZ512308A (en) * 1998-12-01 2004-01-30 Aventis Pasteur Chlamydia antigens and corresponding DNA fragments and uses thereof
AU3790900A (en) 1998-12-01 2000-06-19 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
EP2172214A3 (en) 1999-03-12 2011-03-16 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
WO2000066739A2 (en) * 1999-05-03 2000-11-09 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
CA2385325C (en) * 1999-09-20 2012-04-10 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US20010048927A1 (en) 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
ATE440861T1 (de) * 2000-07-03 2009-09-15 Novartis Vaccines & Diagnostic Immunisierung gegen chlamydia pneumoniae
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
EP3452197A4 (en) 2016-05-04 2020-01-22 Children's Hospital & Research Center at Oakland FAST EXTRACTION OF NUCLEIC ACIDS FROM CLINICAL SAMPLES FOR DOWNSTREAM APPLICATIONS
US20220221456A1 (en) * 2019-05-06 2022-07-14 Arocell Ab Respiratory infection detection and classification

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU692889B2 (en) * 1994-08-03 1998-06-18 Hitachi Chemical Company, Ltd. Monoclonal antibodies having a reactivity specific to Chlamydia pneumoniae, method for production of the monoclonal antibodies, such antibody producing cells, method for production of the cells, method for detection and/or measurement of Chlamydia pneumoniae, reagents for the method, method and agents for diagnosis of chlamydia pneumoniae infection
CN100365017C (zh) 1994-09-20 2008-01-30 日立化成工业株式会社 肺炎衣原体抗原多肽
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
ATE323164T1 (de) 2006-04-15
US20080226679A1 (en) 2008-09-18
JP2002510970A (ja) 2002-04-09
EP1007685A2 (en) 2000-06-14
ES2264810T3 (es) 2007-01-16
WO1998058953A2 (en) 1998-12-30
AU749382B2 (en) 2002-06-27
AU8011998A (en) 1999-01-04
DK1007685T3 (da) 2006-08-14
WO1998058953A3 (en) 1999-03-18
US7264941B1 (en) 2007-09-04
DE69834194D1 (de) 2006-05-24
CN1249233C (zh) 2006-04-05
DE69834194T2 (de) 2007-03-29
BR9810288A (pt) 2000-09-19
CN1261403A (zh) 2000-07-26
EP1007685B1 (en) 2006-04-12
JP4160640B2 (ja) 2008-10-01
CA2294651A1 (en) 1998-12-30

Similar Documents

Publication Publication Date Title
RU2339646C2 (ru) Гибридная и тандемная экспрессия белков нейссерий
DE69834194D1 (de) Oberfläche-exponierte proteine von chlamydia pneumoniae
DE69431995D1 (de) Stabile Produkte des bakterientötenden/durchlässigkeiterhöhenden Proteins (PBI) und diese enthaltende Arzneimittelzusammensetzungen
BR0208944A (pt) quadros de leitura aberta de streptococus pneumoniae codificando os antìgenos de polipeptìdeos e seus usos
WO2002090502A3 (en) Highly conserved proteins from gram-positive bacteria
EP1613345A4 (en) COMPOSITIONS AND METHODS WITH THE RESPIRATORY SYNCYTIAL VIRUS SUB-GROUP B STAMM 9320
FR2828405B1 (fr) Vaccin anti-coronavirus
DK1075523T3 (da) Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf
DE60126602D1 (de) Neue collectine
DE60041042D1 (de) Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon
EE200000478A (et) Peptiid, seda kodeeriv geen, diagnostiline reagent ja diagnostiline reaktiivikomplekt ning vaktsiinkasutamiseks riketsioosi ravis
DE60138621D1 (de) Neuartige glykosyltransferase-gene
MX9805158A (es) Adn que codifica una proteina activadora de plasminogeno.
WO2004053117A3 (en) Serine protease
MXPA05009954A (es) Familia de proteinas secretadas.
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
WO2002033058A3 (en) Novel cysteine proteases and uses thereof
WO2003000717A3 (de) Identifizierung von ses-3 (spr-5) aus c. elegans sowie dessen verwendungen
AU2001239262A1 (en) Haemophilus influenza outer membrane protein and use thereof in vaccination
WO2002050116A3 (en) Adhesion molecule protein
BR0107799A (pt) Proteìna de interação de wt1 wtip
WO2002008393A3 (en) Serine protease from yersinia enterocolitica
WO2002046380A3 (en) Protein kinase
WO2002034901A8 (en) Protein kinase
WO2002062845A3 (en) Adhesion molecules